Original Thymosin Alpha-1: Discovery & Research History
Thymosin Alpha-1 (Thymic Peptide) — how it was originally isolated, and what it has been studied for since.
How Thymosin Alpha-1 Was Discovered
Thymosin Alpha-1 was isolated in 1972 by Allan Goldstein and colleagues, working from a partially purified calf-thymus extract Goldstein's laboratory called “Thymosin Fraction 5,” developed over the preceding years in pursuit of immune-restorative compounds from thymic tissue. Thymosin Alpha-1 turned out to be one of the most biologically active peptides isolated from that fraction.
Despite sharing a thymic naming lineage with TB-500's parent molecule, thymosin beta-4, Thymosin Alpha-1 is a structurally and functionally distinct compound. Its research base centers on immune-system modulation — specifically TLR3/4/9 receptor binding and downstream NF-κB/IRF3 signaling that promotes the maturation and activation of dendritic cells, macrophages, and T-cells — rather than the wound-healing and cytoskeletal research associated with thymosin beta-4.
What Thymosin Alpha-1 Has Been Studied For
Synthetic Thymosin Alpha-1 was later developed commercially as thymalfasin (brand name Zadaxin) by SciClone Pharmaceuticals, and is now an approved prescription medicine in more than 35 countries for chronic hepatitis B and C. A large modern Phase 3 sepsis trial (TESTS, 2025) found no significant survival benefit, making it a useful case study in how strong historical approval data doesn't always extend to newer indications.
- Immune-system modulation research
- TLR3/4/9 receptor and NF-κB/IRF3 signaling studies
- Sepsis and critical-care trial research
Read our Healing & Recovery research overview →
Thymosin Alpha-1 discovery & history questions
Does Thymosin Alpha-1's research history mean it's approved for a particular use?
No. This page describes how Thymosin Alpha-1 was originally isolated and what it has been studied for since — it is historical and educational context, not a claim about current regulatory approval, safety, or legal status anywhere. Any Thymosin Alpha-1 sourced through KYIN Peptides is for laboratory research use only.
What has Thymosin Alpha-1 been studied for in research?
Thymosin Alpha-1 is studied for immune-system modulation, and as thymalfasin (Zadaxin) is an approved prescription medicine in 35+ countries for chronic hepatitis B and C.
Interested in sourcing Thymosin Alpha-1?
Not part of our standard catalogue, but available to order — contact us and we'll help you source it.